Literature DB >> 21211845

Fundus albipunctatus associated with compound heterozygous mutations in RPE65.

Patrik Schatz1, Markus Preising, Birgit Lorenz, Birgit Sander, Michael Larsen, Thomas Rosenberg.   

Abstract

PURPOSE: To describe a family with an 18-year-old woman with fundus albipunctatus and compound heterozygous mutations in RPE65 whose unaffected parents and 1 female sibling harbored single heterozygous RPE65 mutations.
DESIGN: Observational study. PARTICIPANTS: Four family members.
METHODS: Clinical examinations included full-field electroretinogram (ffERG) after standard (30-minute) and prolonged (17-hour) dark adaptation, multifocal electroretinogram (mfERG), optical coherence tomography (OCT), and fundus autofluorescence (FAF). Molecular genetic testing included sequencing of RDH5 and RLBP1 and screening for known autosomal-recessive retinitis pigmentosa mutations by a commercially available microarray technique. RPE65 sequencing was performed after the identification of a known heterozygous splice-site mutation by array screening. MAIN OUTCOME MEASURES: We recorded ffERG and mfERG amplitudes, OCT characteristics, the FAF intensity index, and the outcomes of DNA sequencing regarding RPE65 mutations.
RESULTS: Uniform, yellow-white dots typical of fundus albipunctatus were demonstrated in the proband. These dots corresponded with discrete, hyperreflective formations extending from the Bruch's membrane and retinal pigment epithelium (RPE) into the level of the external limiting membrane, thus spanning along the entire RPE and photoreceptor outer and inner segments. A reduced thickness of the central retina and the RPE-outer segment complex was demonstrated. The intensity of the FAF was severely reduced in the entire fundus. At age 18, ffERG-including prolonged dark adaptation-demonstrated a barely recordable rod response after standard dark adaptation and normalization (increase by more than 700%) of the response after prolonged dark adaptation. The cone 30-Hz flicker response was reduced after standard dark adaptation and increased by >50% after prolonged dark adaptation. In addition, mfERG demonstrated reduced central and peripheral responses. Molecular genetic analysis demonstrated compound heterozygous mutations (IVS1+5G>A and c.344T>C) in RPE65. No mutations were found in RDH5 or RLBP1. No significant abnormalities of retinal structure or function were detected in the parents and sister carrying single heterozygous mutations in RPE65.
CONCLUSIONS: This is the first reported association between compound heterozygous RPE65 mutations and fundus albipunctatus, indicative of a mutation-specific phenotypic effect in this gene. This finding, together with the reduced FAF, supports that disruption of retinoid recycling in the RPE is essential for the development of fundus albipunctatus.
Copyright © 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21211845     DOI: 10.1016/j.ophtha.2010.09.005

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  24 in total

Review 1.  Multimodal fundus imaging in fundus albipunctatus with RDH5 mutation: a newly identified compound heterozygous mutation and review of the literature.

Authors:  Nan-Kai Wang; Lan-Hsin Chuang; Chi-Chun Lai; Chai Lin Chou; Hsueh-Yen Chu; Ling Yeung; Yen-Po Chen; Kuan-Jen Chen; Wei-Chi Wu; Tun-Lu Chen; An-Ning Chao; Yih-Shiou Hwang
Journal:  Doc Ophthalmol       Date:  2012-06-06       Impact factor: 2.379

2.  Late-onset night blindness with peripheral flecks accompanied by progressive trickle-like macular degeneration.

Authors:  Kazushige Tsunoda; Kaoru Fujinami; Kazutoshi Yoshitake; Takeshi Iwata
Journal:  Doc Ophthalmol       Date:  2019-07-08       Impact factor: 2.379

3.  Retinal structure in vitamin A deficiency as explored with multimodal imaging.

Authors:  Tomas S Aleman; Sean T Garrity; Alexander J Brucker
Journal:  Doc Ophthalmol       Date:  2013-07-31       Impact factor: 2.379

4.  Large Benefit from Simple Things: High-Dose Vitamin A Improves RBP4-Related Retinal Dystrophy.

Authors:  Vasily M Smirnov; Baptiste Wilmet; Marco Nassisi; Christel Condroyer; Aline Antonio; Camille Andrieu; Céline Devisme; Serge Sancho; José-Alain Sahel; Christina Zeitz; Isabelle Audo
Journal:  Int J Mol Sci       Date:  2022-06-13       Impact factor: 6.208

5.  A novel mutation in RDH5 gene causes retinitis pigmentosa in consanguineous Pakistani family.

Authors:  Neelam Sultan; Irfan Ali; Shazia Anwer Bukhari; Shahid Mahmood Baig; Muhammad Asif; Muhammad Qasim; Muhammad Imran Naseer; Mahmood Rasool
Journal:  Genes Genomics       Date:  2018-02-03       Impact factor: 1.839

Review 6.  Clinical Perspective: Treating RPE65-Associated Retinal Dystrophy.

Authors:  Albert M Maguire; Jean Bennett; Elena M Aleman; Bart P Leroy; Tomas S Aleman
Journal:  Mol Ther       Date:  2020-12-03       Impact factor: 11.454

7.  RPE65-associated inherited retinal diseases: consensus recommendations for eligibility to gene therapy.

Authors:  Andrea Sodi; Sandro Banfi; Francesco Testa; Michele Della Corte; Ilaria Passerini; Elisabetta Pelo; Settimio Rossi; Francesca Simonelli
Journal:  Orphanet J Rare Dis       Date:  2021-06-04       Impact factor: 4.123

8.  A tapetal-like fundus reflex in a healthy male: evidence against a role in the pathophysiology of retinal degeneration?

Authors:  Patrik Schatz; Jesper Bregnhøj; Henrik Arvidsson; Dror Sharon; Liliana Mizrahi-Meissonnier; Birgit Sander; Karen Grønskov; Michael Larsen
Journal:  Mol Vis       Date:  2012-05-02       Impact factor: 2.367

9.  Fundus albipunctatus: novel mutations and phenotypic description of Israeli patients.

Authors:  Eran Pras; Elon Pras; Haike Reznik-Wolf; Dror Sharon; Svetlana Raivech; Yaniv Barkana; Almogit Abu-Horowitz; Rotenstreich Ygal; Eyal Banin
Journal:  Mol Vis       Date:  2012-06-23       Impact factor: 2.367

10.  Novel mutations in RDH5 cause fundus albipunctatus in two consanguineous Pakistani families.

Authors:  Muhammad Ajmal; Muhammad Imran Khan; Kornelia Neveling; Yar Muhammad Khan; Syeda Hafiza Benish Ali; Waqas Ahmed; Muhammad Safdar Iqbal; Maleeha Azam; Anneke I den Hollander; Rob W J Collin; Raheel Qamar; Frans P M Cremers
Journal:  Mol Vis       Date:  2012-06-13       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.